Keyphrases
Addiction
12%
Agent Efficacy
12%
Ataxia Telangiectasia
100%
Breakage
12%
Cancer Therapeutics
12%
Cell Cycle Checkpoint
12%
Cell Cycle Progression
12%
Cellular Response
12%
Checkpoint Kinase 1 (CHK1)
37%
Chemoresistance
100%
Clinical Trials
12%
DNA Damage Response
12%
DNA Replication Stress
12%
Downstream Effectors
12%
Dysregulation
12%
In Cancer
100%
Malignancy
12%
Origin Initiation
12%
Pathway Control
12%
Promising Target
12%
Rad3
100%
Related Pathway
12%
Replication Fork
25%
Replication Initiation
12%
Replication Origin
12%
Replication Stress
25%
Signaling Pathway
100%
Small Molecule Inhibitors
12%
Stall
12%
Tumor
12%
Tumor Cells
12%
Unresolved Issues
12%
Medicine and Dentistry
Addictive Behavior
12%
Ataxia Telangiectasia
100%
Cancer
12%
Cell Cycle Checkpoint
12%
Cell Cycle Progression
12%
Cell Signaling Pathway
100%
Chemotherapy
12%
Clinical Trial
12%
DNA Damage Response
12%
DNA Synthesis
25%
Drug Resistance
100%
Malignant Neoplasm
100%
Neoplasm
12%
Origin of Replication
12%
Tumor Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ataxia Telangiectasia
100%
Clinical Trial
12%
Drug Resistance
100%
Malignant Neoplasm
100%
Neoplasm
25%
Preclinical Study
12%
Biochemistry, Genetics and Molecular Biology
Ataxia Telangiectasia and Rad3 Related
100%
Cell Cycle Checkpoint
14%
Cell Cycle Progression
14%
Clinical Trial
14%
DNA Damage Response
14%
DNA Synthesis
28%
Drug Resistance
100%
Origin of Replication
14%
Preclinical Study
14%
Small Molecule
14%